Clinical and Translational Oncology

SJR Rank #6,503H-index: 69SJR: 0.833Best quartile: Q2APC: US$4,690
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q2
  • OncologyQ2
  • Cancer ResearchQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsBreast Cancer Treatment StudiesLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesColorectal Cancer Treatments and StudiesFerroptosis and cancer prognosisAdvanced Radiotherapy TechniquesHead and Neck Cancer StudiesGlioma Diagnosis and Treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

202220250150300450600

Detailed Information

ISSN

1699-048X, 1699-3055

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.81

References per Document

47.51

Coverage

2000-2026

Scope

Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.

Metrics from SCImago Journal Rank 2025. View on SCImago